Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel Litwin

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Molecular Cancer Therapeutics|February 4, 2015
Targeted Blockade of JAK/STAT3 Signaling Inhibits Ovarian Carcinoma GrowthGalina Gritsina, Fang Xiao, Shane W O'Brien, et al.
Oncogene|May 19, 2018
NEDD9 promotes oncogenic signaling, a stem/mesenchymal gene signature, and aggressive ovarian cancer growth in miceRashid Gabbasov, Fang Xiao, Caitlin G Howe, et al.
JCI Insight|December 15, 2020
Identification of Wee1 as a target in combination with avapritinib for gastrointestinal stromal tumor treatmentShuai Ye, Dinara Sharipova, Marya Kozinova, et al.
Cancer Chemotherapy and Pharmacology|May 6, 2009
Pharmacokinetic analysis of irinotecan plus bevacizumab in patients with advanced solid tumorsCrystal S Denlinger, Rebecca Blanchard, Lu Xu, et al.
Cancer Research|September 17, 2008
One-hit effects in cancer: altered proteome of morphologically normal colon crypts in familial adenomatous polyposisAnthony T Yeung, Bhavinkumar B Patel, Xin-Ming Li, et al.
British Journal of Cancer|March 11, 2020
Pembrolizumab monotherapy in patients with previously treated metastatic high-grade neuroendocrine neoplasms: joint analysis of two prospective, non-randomised trialsNamrata Vijayvergia, Arvind Dasari, Mengying Deng, et al.
Cancer Biology & Therapy|May 9, 2018
In Vitro and In Vivo evaluation of a novel folate-targeted theranostic nanoemulsion of docetaxel for imaging and improved anticancer activity against ovarian cancersNiravkumar R Patel, Aleksandr Piroyan, Srinivas Ganta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2019
Linsitinib (OSI-906) for the Treatment of Adult and Pediatric Wild-Type Gastrointestinal Stromal Tumors, a SARC Phase II StudyMargaret von Mehren, Suzanne George, Michael C Heinrich, et al.
Pancreas|January 13, 2009
Proteomic analyses of pancreatic cyst fluidsEileen Ke, Bhavinkumar B Patel, Tiffany Liu, et al.
Clinical Lung Cancer|July 14, 2023
Phase II Randomized Trial of Carboplatin, Pemetrexed, and Bevacizumab With and Without Atezolizumab in Stage IV Nonsquamous Non-Small-Cell Lung Cancer Patients Who Harbor a Sensitizing EGFR Mutation or Have Never SmokedJ Nicholas Bodor, Jyoti D Patel, Heather A Wakelee, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Molecular Cancer Therapeutics|February 4, 2015
Targeted Blockade of JAK/STAT3 Signaling Inhibits Ovarian Carcinoma GrowthGalina Gritsina, Fang Xiao, Shane W O'Brien, et al.
Oncogene|May 19, 2018
NEDD9 promotes oncogenic signaling, a stem/mesenchymal gene signature, and aggressive ovarian cancer growth in miceRashid Gabbasov, Fang Xiao, Caitlin G Howe, et al.
JCI Insight|December 15, 2020
Identification of Wee1 as a target in combination with avapritinib for gastrointestinal stromal tumor treatmentShuai Ye, Dinara Sharipova, Marya Kozinova, et al.
Cancer Chemotherapy and Pharmacology|May 6, 2009
Pharmacokinetic analysis of irinotecan plus bevacizumab in patients with advanced solid tumorsCrystal S Denlinger, Rebecca Blanchard, Lu Xu, et al.
Cancer Research|September 17, 2008
One-hit effects in cancer: altered proteome of morphologically normal colon crypts in familial adenomatous polyposisAnthony T Yeung, Bhavinkumar B Patel, Xin-Ming Li, et al.
British Journal of Cancer|March 11, 2020
Pembrolizumab monotherapy in patients with previously treated metastatic high-grade neuroendocrine neoplasms: joint analysis of two prospective, non-randomised trialsNamrata Vijayvergia, Arvind Dasari, Mengying Deng, et al.
Cancer Biology & Therapy|May 9, 2018
In Vitro and In Vivo evaluation of a novel folate-targeted theranostic nanoemulsion of docetaxel for imaging and improved anticancer activity against ovarian cancersNiravkumar R Patel, Aleksandr Piroyan, Srinivas Ganta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2019
Linsitinib (OSI-906) for the Treatment of Adult and Pediatric Wild-Type Gastrointestinal Stromal Tumors, a SARC Phase II StudyMargaret von Mehren, Suzanne George, Michael C Heinrich, et al.
Pancreas|January 13, 2009
Proteomic analyses of pancreatic cyst fluidsEileen Ke, Bhavinkumar B Patel, Tiffany Liu, et al.
Clinical Lung Cancer|July 14, 2023
Phase II Randomized Trial of Carboplatin, Pemetrexed, and Bevacizumab With and Without Atezolizumab in Stage IV Nonsquamous Non-Small-Cell Lung Cancer Patients Who Harbor a Sensitizing EGFR Mutation or Have Never SmokedJ Nicholas Bodor, Jyoti D Patel, Heather A Wakelee, et al.
Pageof 8